Brodalumab for the treatment of moderate to severe plaque psoriasis : An Evidence Review Group Evaluation of a NICE Single Technology Appraisal

Wade, Ros orcid.org/0000-0002-8666-8110, Grosso, Alessandro, South, Emily orcid.org/0000-0003-2187-4762 et al. (5 more authors) (2019) Brodalumab for the treatment of moderate to severe plaque psoriasis : An Evidence Review Group Evaluation of a NICE Single Technology Appraisal. Pharmacoeconomics. pp. 131-139. ISSN 1170-7690

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Crown 2018. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details
Keywords: Journal Article,Review
Dates:
  • Accepted: 24 July 2018
  • Published (online): 16 August 2018
  • Published: 22 January 2019
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Reviews and Dissemination (York)
The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York)
Depositing User: Pure (York)
Date Deposited: 24 Jul 2018 23:55
Last Modified: 14 Oct 2019 23:22
Published Version: https://doi.org/10.1007/s40273-018-0698-2
Status: Published
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40273-018-0698-2

Download

Filename: Brodalumab_for_psoriasis_revised_clean.docx

Description: Brodalumab for psoriasis revised clean

Share / Export

Statistics